Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]
Dong-A ST and Beactica Therapeutics Mutually Agree to Conclude Oncology Collaboration
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, […]
Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer
Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]
RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy
A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. […]
Ibex and Medipath Sign Multi-Year, Multi-Site and Multi-Tissue Expansion of AI for Cancer Diagnosis Across France
Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, and Medipath, the largest network of private […]
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition […]
Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The […]
Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings
MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]
Mendus Announces Financing Commitments Totaling Up to SEK 250 Million With Van Herk Investments and Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company addressing tumor recurrence through cell-based immunotherapies, today announces […]
PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb
PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more